Skip to the page

Data / Form D filings / IM Cannabis Corp.

IM Cannabis Corp.: Form D filings

IM Cannabis Corp., a pharmaceuticals company in Central District, Israel, filed 5 Form D notices with the SEC between 2019 and 2024. The latest, on November 20, 2024, reports $26,893 sold of a $67,234 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
KIBBUTZ GLIL YAM, Central District, Israel, 46905
Phone
(416) 256-4202
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
British Columbia, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1792030

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 20, 2024New notice$67,234$26,893$40,3411Nov 12, 2024sec.gov
Jul 9, 2020New notice$302,077$302,0772Jun 26, 2020sec.gov
Jul 9, 2020New notice$11,527$11,5271Jun 17, 2020sec.gov
Oct 24, 2019New notice$336,703$0$336,7035Oct 11, 2019sec.gov
Oct 24, 2019New notice$3,221,811$0$3,221,81111Oct 11, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Oren ShusterExecutive Officer, Director
Moti MarcusDirector
Einat ZakariyaDirector
Brian SchinderleDirector
Shmulik ArbelDirector
Michal Lebovitz NissimovExecutive Officer
Richard BallaExecutive Officer
Uri BirenbergExecutive Officer

Every Form D from the week of Nov 18, 2024 · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what IM Cannabis Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.